.png){kind=logo}
NICE TO MEET YOU
We serve as an unbiased integrated and collaborative platform for technology providers, industry experts, nutraceutical companies, animal protein producers and consumers to support "One Health"
Non-Antibiotic Antimicrobial Compounds
Cutting-edge synergistic technologies at the forefront:
Phage therapy, bioactive peptides, viral inhibitors.
Manufacturing in Poland
Quality Assurance GMP
Collaborative research withacademic institutions
21+ products in portfolio
Innova Biotechnology is incorporated in Poland.
We are focused on the discovery, production and marketing of innovative non-antibiotic products to control bacterial pathogens in environmental, food processing, and medical settings.
We use precision biology to modulate the microbiome to improve animal and human health, increasing environmental sustainability and eliminating the unnecessary use of antibiotics.
We develop and manufacture non-antibiotic compounds that offer environmentally friendly, natural, and sustainable solutions to address antimicrobial challenges across human health, agriculture, livestock, aquaculture, and companion animal care.
Innova Biotechnology: Geo Presence
The Sustainable Development Goals are the blueprint to achieve a better and more sustainable future for all. They address the global challenges we face, including those related to poverty, inequality, climate change, environmental degradation, peace and justice.
Nasze rozwiązania bezpośrednio przyczyniają się do:
OUR TEAM
Nipun Gupta
Managing Director (Strategy and Investor relationship)
Drawing upon over 20 years of experience, Nipun is responsible for implementing growth strategies. With a proven track record of success, he has spearheaded numerous commercial management operations and facilitated global commercial growth for biotechnology start-ups, VC-financed telecommunication projects, and Global IT & Telcos. His focus is always on achieving business objectives.
Dr. Paolo Doncecchi
Chief Product Officer
Responsible for global sales and marketing. An energetic and resilient business manager with 35 years of experience in sales and marketing to deliver consistent P&L results in animal health (swine, poultry and cattle).
Paweł Kotula
Chief Operating and Finance Officer
With over 12 years of management experience, Paweł has served as a Board Member of Proteon Pharmaceuticals India and as Head of Business Planning & Analysis for a global telecommunications operator.
Tomasz Nowakowski
Business Development Director, Europe
Tomasz Nowakowski is a results-driven Sales Leader with over 20 years of experience spearheading B2B and B2C sales initiatives including biotechnology. Currently serving as Business Development Director, Europe at lnnova Biotechnology (Poland), he leads business growth in the animal biotechnology domain.
Pramod Kumar Singh
Country Manager - ISC & SEA I Senior Sales Leader I Biotechnology I B2B & B2C Strategy Expert
Accomplished and strategic Sales Leader with over 35 years of experience driving sustainable revenue growth and market leadership across the Indian Subcontinent (ISC) and Southeast Asia (SEA) regions. Proven expertise in leading cross-functional teams, executing high-impact sales strategies, and managing complex 82B and B2C operations within the biotechnology industry. Renowned for delivering consistent national and regional growth through innovative market expansion, strategic key account management, and customer-centric leadership. Adept at building long-term client relationships, navigating competitive landscapes, and exceeding performance benchmarks.
Ashish Narayan
Commercial Manager - Companion Animals
(Americas & Asia-Pacific)
Specializing in the international companion animal market, Ashish stands out for his commitment to advancing animal welfare and health. Expert in driving revenue growth through strategic innovation and customer-centric approaches across B2B and B2C segments. Skilled at building and maintaining relationships with key stakeholders including veterinarians, distributors, and pet owners worldwide to create meaningful value for pets, owners, and the global community through market insights and forward-thinking strategies.